Evidence map›Paper›PMID 26744626›Full record

ArticleJournal of intensive care2016

Red cell transfusions as an independent risk for mortality in critically ill children.

Surender Rajasekaran, Eric Kort, Richard Hackbarth, Alan T Davis, Dominic Sanfilippo, Robert Fitzgerald, Sandra Zuiderveen, Akunne N Ndika, Hilary Beauchamp, Anthony Olivero and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of intensive care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2018
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants.Journal of perinatology : official journal of the California Perinatal Association · 2019
    Article
  13. The bloody mess of red blood cell transfusion.Critical care (London, England) · 2017
    Review
  14. Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Surender RajasekaranDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Eric KortDepartment of Pediatric Hospitalists, Helen DeVos Children's Hospital, Grand Rapids, MI USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Richard HackbarthDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Alan T DavisDepartment of Research, Grand Rapids Medical Education Partners and Michigan State University, Grand Rapids, MI USA ; Department of Surgery, Michigan State University, Grand Rapids, MI USA.
Dominic SanfilippoDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Robert FitzgeraldDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Sandra ZuiderveenDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA.
Akunne N NdikaDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA.
Hilary BeauchampDepartment of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Anthony OliveroDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Nabil HassanDepartment of Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, 100 Michigan St N.E., Grand Rapids, MI 49503 USA ; Department of Pediatrics, Michigan State University College of Human Medicine. Grand Rapids, Grand Rapids, MI USA.
Helen DeVos Children's Hospital · USGrand Rapids Community College · USMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeverity of illness is an important consideration in making the decision to transfuse as it is the sicker patient that often needs a red cell transfusion. Red blood cell (RBC) transfusions could potentially have direct effects and interact with presenting illness by contributing to pathologies such as multi-organ dysfunction and acute lung injury thus exerting a considerable impact on overall morbidity and mortality. In this study, we examine if transfusion is an independent predictor of mortality, or if outcomes are merely a result of the initial severity as predicted by Pediatric Risk of Mortality (PRISM) III, Pediatric Index of Mortality (PIM2), and day 1 Pediatric Logistic Organ Dysfunction (PELOD) scores.

methodsA single center retrospective study was conducted using data from a prospectively maintained transfusion database and center-specific data at our pediatric ICU between January 2009 and December 2012. Multivariate regression was used to control for the effects of clinical findings, therapy, and severity scores, with mortality as the dependent variable. Likelihood ratios and area under the curve were used to test the fidelity of severity scores by comparing transfused vs. non-transfused patients.

resultsThere were 4975 admissions that met entry criteria. In multivariate analysis, PRISM III scores and serum hemoglobin were significant predictors of transfusion (p < 0.05). Transfused and non-transfused subjects were distinctly disparate, so multivariate regression was used to control for differences. Severity scores, age, volume transfused, and vasoactive agents were significantly associated with mortality whereas hemoglobin was not. A substantial number of transfusions (45 %) occurred in the first 24 h, and patients transfused later (24-48 h) were more likely to die compared to this earlier time point. Likelihood ratio testing revealed statistically significant differences in severity scoring systems to predict mortality in transfused vs. non-transfused patients.

conclusionsThis study suggests that RBC transfusion is an important risk factor that is statistically independent of severity. The timing of transfusions that related strongest to mortality remained outside the purview of severity scoring, as these happened beyond the timing of data collection for most scoring systems.

Indexed as

Acuity scoresMortality predictionPediatric critical carePediatric outcome scoresPELODPIM2PRISMTransfusion

Identifiers

PMID26744626
PMCPMC4704419
OpenAlexW2227358508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.